We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16.5B
AUM Growth
+$1.75B
Cap. Flow
+$507M
Cap. Flow %
3.07%
Top 10 Hldgs %
21.55%
Holding
964
New
170
Increased
275
Reduced
467
Closed
23

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$36.4M
2
FIS icon
Fidelity National Information Services
FIS
+$36M
3
ALLE icon
Allegion
ALLE
+$31.9M
4
MDT icon
Medtronic
MDT
+$28.1M
5
CVX icon
Chevron
CVX
+$27.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$36.2M
2
UNH icon
UnitedHealth
UNH
+$27.4M
3
CELG
Celgene Corp
CELG
+$25M
4
HES
Hess
HES
+$22M
5
CCI icon
Crown Castle
CCI
+$20.6M

Sector Composition

Rank Sector Weight
1 Technology 18.29%
2 Financials 16.69%
3 Healthcare 13.55%
4 Consumer Discretionary 10.79%
5 Communication Services 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
151
General Dynamics
GD
$104B
$20.5M 0.12%
116,197
-1,128
-1% -$203K
ITW icon
152
Illinois Tool Works
ITW
$83.8B
$20.4M 0.12%
113,344
-1,148
-1% -$195K
JKHY icon
153
Jack Henry & Associates
JKHY
$11.5B
$20.3M 0.12%
139,082
+18,582
+15% +$2.71M
PXD
154
DELISTED
Pioneer Natural Resource Co.
PXD
$19.8M 0.12%
130,576
+3,580
+3% +$477K
VRTX icon
155
Vertex Pharmaceuticals
VRTX
$123B
$19.7M 0.12%
90,089
-504
-0.6% -$102K
SLB icon
156
SLB Ltd
SLB
$73.3B
$19.6M 0.12%
486,691
-2,665
-0.5% -$95.2K
SCHW
157
Charles Schwab
SCHW
$183B
$19.3M 0.12%
405,590
-10,172
-2% -$448K
DE icon
158
Deere & Co
DE
$165B
$19.3M 0.12%
111,269
-1,044
-0.9% -$180K
CSX icon
159
CSX Corp
CSX
$94.1B
$19.1M 0.12%
791,409
-16,449
-2% -$389K
BIIB icon
160
Biogen
BIIB
$30.7B
$18.9M 0.11%
63,836
-1,153
-2% -$320K
ELV icon
161
Elevance Health
ELV
$81.8B
$18.9M 0.11%
62,644
-3,033
-5% -$835K
CCK icon
162
Crown Holdings
CCK
$13B
$18.7M 0.11%
257,232
+230,511
+863% +$16.4M
NOW icon
163
ServiceNow
NOW
$121B
$18.5M 0.11%
327,320
-1,420
-0.4% -$74.8K
BN icon
164
Brookfield
BN
$103B
$18.3M 0.11%
889,273
+51,931
+6% +$1.04M
PSA icon
165
Public Storage
PSA
$61.5B
$18.2M 0.11%
85,675
+936
+1% +$208K
APD icon
166
Air Products & Chemicals
APD
$65.7B
$18.2M 0.11%
77,314
-345
-0.4% -$77.9K
NSC icon
167
Norfolk Southern
NSC
$75.6B
$17.9M 0.11%
92,271
-1,613
-2% -$303K
SU icon
168
Suncor Energy
SU
$77.7B
$17.8M 0.11%
544,863
-10,586
-2% -$330K
EOG icon
169
EOG Resources
EOG
$77.5B
$17.7M 0.11%
211,649
+425
+0.2% +$31.1K
PSX icon
170
Phillips 66
PSX
$83B
$17.5M 0.11%
157,514
-1,474
-0.9% -$166K
TRP icon
171
TC Energy
TRP
$69.9B
$17.5M 0.11%
328,711
+4,205
+1% +$216K
BMO icon
172
Bank of Montreal
BMO
$124B
$17.4M 0.11%
224,999
-600
-0.3% -$45.2K
HUM icon
173
Humana
HUM
$44.2B
$17.3M 0.1%
47,145
-468
-1% -$148K
LHX icon
174
L3Harris
LHX
$55.2B
$17.2M 0.1%
86,791
+8,875
+11% +$1.78M
ILMN icon
175
Illumina
ILMN
$29.4B
$17.1M 0.1%
52,993
-291
-0.5% -$88.2K

Similar funds

Aviva's Q4 2019 Portfolio in Review

As of Q4 2019, Aviva held 964 positions worth $16.5B, up 12% from $14.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aviva deployed $507M of net new capital in Q4 2019, opening 170 new positions and adding to 275 existing holdings. Its largest new stake was ON Semiconductor: 1,068,449 shares worth $26M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $36.2M trimmed.

  • Aviva's largest Q4 2019 buy was ON Semiconductor: 1,068,449 shares worth $26M.
  • Aviva added most to Alibaba in Q4 2019, an estimated $36.4M increase.
  • Aviva's biggest Q4 2019 reduction was Apple, cutting an estimated $36.2M.
  • Aviva fully exited Celgene Corp in Q4 2019, selling an estimated $25M.
  • Aviva's ten largest holdings make up 22% of its $16.5B portfolio in Q4 2019.
  • Aviva opened 170 new positions and closed 23 in Q4 2019.
  • Aviva's portfolio value rose 12% quarter-over-quarter to $16.5B.

Based on Aviva's 13F filing for Q4 2019, filed 10 Feb 2020.